Basal cell carcinoma, including avohilmo

C3_BASAL_CELL_CARCINOMA_INCLAVO

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Primary healthcare outpatient ICD-10: C44.01, C44.11, C44.21, C44.31, C44.41, C44.51, C44.61, C44.71, C44.81, C44.91

3082

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

3082

diagram downward connector

Check minimum number of events None

3082

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

17318

diagram downward connector
C3_BASAL_CELL_CARCINOMA_INCLAVO

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF7

Summary Statistics

Key figures

All Female Male
Number of individuals 17318 8147 9171
Unadjusted prevalence (%) 4.87 4.11 5.83
Mean age at first event (years) 66.50 64.82 67.99

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.45 [1.23, 1.70] 5.7e-6 2808
15 years 0.01 0.92 [0.81, 1.05] 2.3e-1 1320
5 years 0.00 1.73 [1.55, 1.93] 1.7e-22 865
1 year 0.00 2.20 [1.86, 2.61] 7.0e-20 214

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_BASAL_CELL_CARCINOMA_INCLAVO – Basal cell carcinoma, including avohilmo
GWS hits:

Survival analyses between endpoints

Plot

before Basal cell carcinoma, including avohilmo
after Basal cell carcinoma, including avohilmo

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Basal cell carcinoma, including avohilmo